Zealand Pharma A/S. - ADR
ZEAL
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
$47.02
167.3% upside
Current Fair Value
167.3% upsideUndervalued by 167.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-278,524,000.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-26.54 |
| Beta | 1.34 |
| Outstanding Shares | 43,634,412 |
Return
| Return on Equity | -140.95% |
|---|---|
| Return on Assets | -54.44% |
| Return on Invested Capital | -75.81% |
Valuation & Multiples
| P/E Ratio | 3.1 |
|---|---|
| PEG | -12.3 |
| Price to Sales | 4.4 |
| Price to Book Ratio | 1.1 |
| Enterprise Value to Revenue | -1.38 |
| Enterprise Value to EBIT | 0.24 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -3.03 |
| Debt to Equity | 1.19 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zealand Pharma A/S.
CEO: Emmanuel Dulac